Not Yet Recruiting
Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
NCT07303283
- Conditions
- Adjuvant Therapy, Carcinoma, Head and Neck Neoplasms, +14 more
- Locations
-
- The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China